Publications by Professor Andrew Fisher - ePrints

Browsing publications by Professor Andrew Fisher.

Newcastle Authors	Title	Year
Dr Mary Neal Saskia Bos Dr Charlotte Holland Dr Kieren Hollingsworth Dr Gerard Meachery et al.	Dynamic ¹⁹F-MRI of pulmonary ventilation in lung transplant recipients with and without chronic lung allograft dysfunction	2025
Nick Chilvers Dr Jenny Gilmour Marnie Brown Lucy Bates Chong Pang et al.	A Split-Lung Ex Vivo Perfusion Model for Time- and Cost-Effective Evaluation of Therapeutic Interventions to the Human Donor Lung	2024
Dr Luke Milross Bethany Hunter Dr David McDonald George Merces Dr Amanda Thomson et al.	Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19	2024
Dr Pauline Pradere Professor Andrew Fisher	Donor to recipient age matching in lung transplantation: A European experience	2024
Professor Andrew Fisher Professor Helen Hancock Professor James Wason Dr Michael Grayling Dr Joanne Lally et al.	Extracorporeal Photopheresis (ECP) in the Treatment of Chronic Lung Allograft Dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK)	2024
Professor Andrew Fisher	Lung Transplantation	2024
Dr Rebeka Jenkins Ben Rimmer Professor Andrew Fisher Professor Linda Sharp Professor Catherine Exley et al.	Measuring patient-reported experience of solid organ transplantation healthcare: A scoping review of condition- and transplant-specific measures	2024
Bethany Hunter Dr Ioana Nicorescu Emma Foster Dr David McDonald Dr Gill Hulme et al.	OPTIMAL: An OPTimized Imaging Mass cytometry AnaLysis framework for benchmarking segmentation and data exploration	2024
Dr Pauline Pradere Saskia Bos Dr Andre Pozza Dr Gerard Meachery Dr James Lordan et al.	Outcomes of listing for lung and heart–lung transplantation in pulmonary hypertension: comparative experience in France and the UK	2024
Phil Mawson Dr Guy MacGowan Professor Neil Sheerin Professor Andrew Fisher Professor James Shaw et al.	SIGNET: protocol for a multicentre, single-blind prospective, group sequential, randomised controlled trial to evaluate the benefits of a single dose of simvastatin given to potential organ donors declared dead by neurological criteria on outcomes in organ recipients	2024
Professor Andrew Fisher	The use of extracorporeal photopheresis in solid organ transplantation—current status and future directions	2024
Dr Luke Milross Bethany Hunter Dr Joaquim Majo Professor Andrew Filby Professor Andrew Fisher et al.	Downregulation of MALAT1 is a hallmark of tissue and peripheral proliferative T cells in COVID-19	2023
Professor Andrew Fisher Dr Bill Scott	FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2	2023
Professor Andrew Fisher Dr Lee Borthwick	Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation	2023
Dr Luke Milross Dr Joaquim Majo Bethany Hunter Professor Andrew Filby Professor Andrew Fisher et al.	Identification of a protein expression signature distinguishing early from organising diffuse alveolar damage in COVID-19 patients	2023
Saskia Bos Dr James Lordan Dr Arun Nair Professor Andrew Fisher Dr Gerard Meachery et al.	Lung transplantation for interstitial lung disease: evolution over three decades	2023
Dr Saskia Bos Dr Pauline Pradere Dr Bart Vanaudenaerde Professor Andrew Fisher	Lymphocyte Depleting and Modulating Therapies for Chronic Lung Allograft Dysfunction	2023
Laura Sabater Jean-Baptiste Gossart Inmaculada Hernandez Lopez Dr Daniel Rico Rodriguez Dr Lee Borthwick et al.	miRNA Expression in Fibroblastic Foci within Idiopathic Pulmonary Fibrosis Lungs Reveals Novel Disease-Relevant Pathways	2023
Tom Pither Dr Lu Wang Lucy Bates Dr Morvern Morrison Catriona Charlton et al.	Modeling the Effects of IL-1β-mediated Inflammation During Ex Vivo Lung Perfusion Using a Split Human Donor Model	2023
Dr Saskia Bos Dr Joaquim Majo Dr Wendy Funston Professor Andrew Fisher Dr Gerard Meachery et al.	Silicone depositions: An unusual finding in the explanted and newly transplanted lungs	2023
Professor John Dark Professor Andrew Fisher	Transplantation of Organs From DCD and DBD Donors Who Died After Ligature Asphyxiation	2023
Dr Lee Borthwick Professor Andrew Fisher	Altered Differentiation and Inflammation Profiles Contribute to Enhanced Innate Responses in Severe COPD Epithelium to Rhinovirus Infection	2022
Teresa Brevini Professor Andrew Fisher Dr Fotis Sampaziotis	Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity	2022
Saskia Bos Dr Luke Milross Professor Andrew Filby Professor Andrew Fisher	Immune processes in the pathogenesis of chronic lung allograft dysfunction: identifying the missing pieces of the puzzle	2022
Saskia Bos Professor Andrew Fisher	Is downregulation of liver kinase B1 the major factor driving epithelial-to-mesenchymal transition?	2022
Dr Luke Milross Dr Joaquim Majo Professor Andrew Filby Professor Andrew Fisher	Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19	2022
Dr Luke Milross Dr Joaquim Majo Bethany Hunter Dr Christopher Duncan Professor Andrew Filby et al.	The trajectory of COVID-19 cardiopulmonary disease: insights from an autopsy study of community-based, pre-hospital deaths	2022
Dr Morvern Morrison Dr Anders Andreasson Catriona Charlton Dr Alisha Chhatwal Dr Bill Scott et al.	Transcriptional analysis identifies potential novel biomarkers associated with successful ex-vivo perfusion of human donor lungs	2022
JinHeng Lin Professor Michael Taggart Dr Lee Borthwick Professor Andrew Fisher Dr Malcolm Brodlie et al.	Acute cigarette smoke or extract exposure rapidly activates TRPA1-mediated calcium influx in primary human airway smooth muscle cells	2021
Dr Luke Milross Chelsea Griffiths Professor Andrew Fisher	Ex Vivo Lung Perfusion: A Platform for Donor Lung Assessment, Treatment and Recovery	2021
Gillian Hardman Professor Andrew Fisher Professor John Dark	Heart transplantation in the UK during the first wave of the SARS-CoV-2 pandemic	2021
Dr Emily Thompson Lucy Bates Dr Ibrahim Ibrahim Dr Avinash Sewpaul Rodrigo Figueiredo et al.	Novel delivery of cellular therapy to reduce ischaemia reperfusion injury in kidney transplantation	2021
Dr Lee Borthwick Ben Barksby Rachel Burgoyne Rory Barnes Professor Andrew Fisher et al.	Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease	2021
Kasim Jiwa Professor Andrew Fisher	Stepwise pathogenic evolution of Mycobacterium abscessus	2021
Professor Andrew Fisher	The Journal of Heart and Lung Transplantation: A golden age draws to a close and a new dawn begins	2021
Gillian Hardman Stephen Clark Karen Booth Professor John Dark Professor Andrew Fisher et al.	The impact of the SARS-CoV-2 pandemic and COVID-19 on lung transplantation in the UK: Lessons learned from the first wave	2021
Rachel Burgoyne Professor Andrew Fisher Dr Lee Borthwick	The role of epithelial damage in the pulmonary immune response	2021
Professor Andrew Fisher	Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis	2021
Professor Andrew Fisher	Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis (Nature Communications, (2019), 10, 1, (6), 10.1038/s41467-018-07858-8)	2020
Dr Christopher Marshall Madeleine Still Akvile Stoniute Professor Dawn Craig Professor Falko Sniehotta et al.	Barriers and facilitators to organ donation in people from minority ethnic backgrounds: a logic model	2020
Dr Christopher Marshall Madeleine Still Akvile Stoniute Professor Dawn Craig Professor Falko Sniehotta et al.	Barriers, facilitators and interventions concerning organ donation in people from minority ethnic backgrounds: updating the evidence base	2020
Dr Julie Worrell Dr Jack Leslie Dr Graham Smith Marco Zaki Dr Hannah Paish et al.	cRel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosis	2020
Dr Jack Leslie Dr Marina Garcia Macia Dr Saimir Luli Dr Julie Worrell William Reilly et al.	c-Rel orchestrates energy-dependant epithelial and macrophage reprogramming in fibrosis	2020
Professor Andrew Fisher Professor John Dark	Ex vivo repair of human donor lungs for transplantation	2020
Dr Jack Leslie Benjamin Millar Alicia Del Carpio Pons Rachel Burgoyne Joseph Frost et al.	FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis	2020
Professor Andrew Fisher Dr James Lordan	Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?	2020
Professor Andrew Fisher	International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation	2020
Gillian Hardman Professor Andrew Fisher Professor John Dark	Lung Transplantation and Utilisation Following Donation after Circulatory Death (DCD) in the UK	2020
Stephen Ball Dr Simon Cockell Emerita Professor Janet Wilson Professor Derek Mann Professor Andrew Fisher et al.	Microarray analysis of primary epithelial and fibroblast cells in chronic rhinosinusitis without nasal polyps	2020
Jenny Gilmour Chelsea Griffiths Tom Pither Dr Bill Scott Professor Andrew Fisher et al.	Normothermic machine perfusion of donor-lungs ex-vivo: promoting clinical adoption	2020
Dr Bill Scott Dr Bill Scott III Professor Simi Ali Professor Andrew Fisher	Normothermic machine perfusion: a platform to assess and treat donor organs ex-situ with novel therapeutics prior to transplantation.	2020
Dr Aaron Ions Gardner Dr Iram Haq Professor John Simpson Dr Vinciane Saint-Criq Dr Bernard Verdon et al.	Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis	2020
Dr Lee Borthwick Professor Andrew Fisher	The circadian clock protein REVERBα inhibits pulmonary fibrosis development	2020
Dr Lee Borthwick Ben Barksby Rachel Burgoyne Rory Barnes Professor Andrew Fisher et al.	Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis	2020
Professor Vijay Kunadian Dr Nina Wilson Dr Deborah Stocken Emerita Professor Elaine McColl Dr Graham Burns et al.	Antiplatelet therapy in the primary prevention of cardiovascular diseasein patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial	2019
Dr Lu Wang Anders Andreasson Dr Andrew Sims Professor Andrew Fisher Stephen Clark et al.	Developing DSA Post-Lung Transplant - Identifying Risk Factors	2019
Neil McDonald Professor Andrew Fisher	Enhanced avidity from a multivalent fluorescent antimicrobial peptide enables pathogen detection in a human lung model	2019
Dr Christopher Marshall Madeleine Still Jenny Hasenfuss Akvile Stoniute Professor Dawn Craig et al.	Identifying interventions to increase organ donation rates in people from minority ethnic backgrounds	2019
Alexandros Chrysos Professor Luke Vale Professor Andrew Fisher	Incorporating ex-vivo lung perfusion into the UK adult lung transplant service: an economic evaluation and decision analytic model	2019
Professor Christopher Ward Dr Gerard Meachery Dr James Lordan Professor Andrew Fisher	Long-term effect of azithromycin in bronchiolitis obliterans syndrome	2019
Dr Lu Wang Professor Andrew Fisher Professor Neil Sheerin Professor John Dark	Severe acute kidney injury after cardiac transplantation is a marker of poor early outcome and impacts on late renal function -- a UK cohort study	2019
Professor Andrew Fisher	The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis	2019
Shameem Sultanali Ladak Jason Powell Professor Andrew Fisher Professor Christopher Ward Professor Simi Ali et al.	The role of miR-200b-3p in modulating TGF-β1 induced injury in human bronchial epithelial cells	2019
Professor Andrew Fisher	Altered DNA methylation is associated with aberrant gene expression in parenchymal but not airway fibroblasts isolated from individuals with COPD	2018
Professor Andrew Fisher	Lung transplantation after allogeneic stem cell transplantation: a pan-European experience	2018
Professor Andrew Fisher	Lung transplantation for scleroderma lung disease: An international, multicenter, observational cohort study	2018
Dr Jodie Birch Dr Katy Hester Dr Gareth Parry Professor Kate Gould Professor John Dark et al.	Outcomes of lung transplantation in adults with bronchiectasis	2018
Professor Andrew Fisher Dr James Lordan Dr Gerard Meachery Dr Bart Vanaudenaerde	An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe	2017
Professor Andrew Fisher	British thoracic society guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)	2017
Professor Andrew Fisher	British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)	2017
Professor Andrew Fisher	Cathepsin K in Lymphangioleiomyomatosis: LAM Cell-Fibroblast Interactions Enhance Protease Activity by Extracellular Acidification	2017
Dr Morvern Morrison Tom Pither Professor Andrew Fisher	Pathophysiology and classification of primary graft dysfunction after lung transplantation	2017
Anders Andreasson Danai Karamanou Dr Colin Gillespie Kasim Jiwa Dr Nicola Green et al.	Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion	2017
Anders Andreasson Professor John Dark Professor Andrew Fisher	Reply to Mohamed S.A. Mohamed	2017
Professor Andrew Fisher	Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part III: Mechanisms: A 2016 Consensus Group Statement of the International Society for Heart and Lung Transplantation	2017
Sasiharan Sithamparanathan Dr Logan Thirugnanasothy Professor Andrew Fisher Dr James Lordan	Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry	2017
Professor Andrew Gennery Julie Guest Professor Andrew Fisher	The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society	2017
Anders Andreasson Dr Lee Borthwick Dr Colin Gillespie Kasim Jiwa Jonathan Scott et al.	The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion	2017
Dr Lee Borthwick Wona Suwara Dr Sonya Carnell Dr Nicola Green Dr Rahul Mahida et al.	Pseudomonas aeruginosa induced Airway Epithelial Injury Drives Fibroblast Activation: A Mechanism in Chronic Lung Allograft Dysfunction	2016
Professor Andrew Fisher Professor John Dark	A Study of Donor Ex-Vivo Lung Perfusion in UK Lung Transplantation (DEVELOP-UK)	2016
Professor Andrew Fisher Anders Andreasson Alexandros Chrysos Dr Joanne Lally Valentina Mamasoula et al.	An observational study of Donor Ex Vivo Lung Perfusion in UK Lung Transplantation : DEVELOP-UK	2016
Dr Logan Thirugnanasothy Sasiharan Sithamparanathan Dr James Lordan Professor Andrew Fisher Dr Guy MacGowan et al.	Establishing The Effect Of Targeted Therapies On Diffusing Capacity In Patients With Pulmonary Arterial Hypertension (PAH)	2016
Dr Lee Borthwick Professor Andrew Fisher	Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis	2016
Sasiharan Sithamparanathan Dr Logan Thirugnanasothy Professor John Dark Professor Andrew Fisher Professor Kate Gould et al.	Observational study of lung transplant recipients surviving 20 years	2016
Sasiharan Sithamparanathan Dr Logan Thirugnanasothy Professor Andrew Fisher Dr James Lordan Dr Gerard Meachery et al.	Observational Study of Methotrexate in the Treatment of Bronchiolitis Obliterans Syndrome	2016
Kasim Jiwa Dr Lee Borthwick Dr Anders Andreasson Professor John Dark Professor Andrew Fisher et al.	Potential therapeutic benefits of the human amniotic epithelium cell secretome during ex-vivo perfusion of donor lungs	2016
Dr Anders Andreasson Professor John Dark Professor Andrew Fisher	Profiling Biomarkers of Inflammation and Tissue Injury during Human Ex Vivo Lung Perfusion in the DEVELOP-UK Study	2016
Professor Andrew Fisher Mohammad Yadegarfar Dr Joanna Collerton Therese Small Emeritus Professor Thomas Kirkwood et al.	Respiratory health and disease in a UK population-based cohort of 85 year olds: The Newcastle 85+ Study	2016
Dr Lee Borthwick Professor Andrew Fisher Professor Christopher Buckley	Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis	2016
Dr Jodie Birch Stella Victorelli Rhys Anderson Kasim Jiwa Dr Elizabeth Moisey et al.	Telomere Dysfunction and Senescence-associated Pathways in Bronchiectasis	2016
Dr Stephen Ball Professor Derek Mann Emerita Professor Janet Wilson Professor Andrew Fisher	The Role of the Fibroblast in Inflammatory Upper Airway Conditions	2016
Dr Gareth Parry Professor Andrew Fisher Dr Gerard Meachery Dr James Lordan	Total Lymphoid Irradiation (TLI) for the Management of Bronchiolitis Obliterans Syndrome (BOS) Post Lung Transplant: A Single Centre Experience	2016
Dr Anders Andreasson Danai Karamanou Dr Colin Gillespie Dr Lee Borthwick Kasim Jiwa et al.	Treating Donor Lung Inflammation by Blocking Interleukin-1B-An In Vitro Therapy Testing Platform for Ex Vivo Lung Perfusion	2016
Mohammad Yadegarfar Professor Andrew Fisher Emerita Professor Carol Jagger	Understanding The Relationship Between Lung Function Measures And Mortality In The Very Old	2016
Vicky Ryan Therese Small Dr James Lordan Professor Andrew Fisher Dr Gerard Meachery et al.	A randomised controlled trial of azithromycin therapy in Bronchiolitis Obliterans Syndrome (BOS) post lung transplantation	2015
Dr Jodie Birch Rhys Anderson Clara Correia Melo Dr Diana Jurk Dr Graeme Hewitt et al.	DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease	2015
Dr Stephen Ball Monika Suwara Dr Lee Borthwick Emerita Professor Janet Wilson Professor Derek Mann et al.	How Reliable are Sino-Nasal Cell Lines for Studying the Pathophysiology of Chronic Rhinosinusitis?	2015
Professor Andrew Fisher	The reversal of pulmonary vascular remodeling through inhibition of p38 MAPK-alpha: a potential novel anti-inflammatory strategy in pulmonary hypertension	2015
Dr Caroline Wilson Dr Lindsay Murphy Jack Leslie Dr Stuart Kendrick Jeremy French et al.	Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease	2015
Dr Anders Andreasson Professor John Dark Professor Andrew Fisher	Ultrastructural Changes in Epithelial and Endothelial Barriers During Ex-Vivo Lung Perfusion	2015
Dr Anders Andreasson Professor John Dark Professor Andrew Fisher	Ex vivo lung perfusion in clinical lung transplantation-State of the art	2014
Amanda Jones Professor Andrew Fisher Dr Rahul Mahida Dr John Perry Ros Brown et al.	Nocardia kroppenstedtii sp nov., an actinomycete isolated from a lung transplant patient with a pulmonary infection	2014
Sasiharan Sithamparanathan Dr Logan Thirugnanasothy Professor Andrew Fisher Dr James Lordan Dr Gerard Meachery et al.	A Retrospective Observational Study of 20 Year Lung Transplant Survivors - A Single Centre Experience	2014
Wona Suwara Dr Nicola Green Dr Lee Borthwick Professor Jelena Mann Professor Andrew Fisher et al.	IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts	2014
Monika Suwara Dr Bart Vanaudenaerde Dr Nicola Green Professor Christopher Ward Dr Lee Borthwick et al.	Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation	2014
Dr James Lordan Dr Gerard Meachery Professor Andrew Fisher Dr Gareth Parry	Pregnancy after lung and heart-lung transplantation	2014
Dr Anders Andreasson Danai Karamanou Dr John Perry Dr Hannah Walden Stephen Clark et al.	The effect of ex vivo lung perfusion on microbial load in human donor lungs	2014
Dr James Lordan Professor Andrew Fisher Dr Bart Vanaudenaerde	The Impact of Air Pollution on Outcome After Lung Transplantation in Europe	2014
Dr Sarah Woolcock Professor Andrew Fisher Dr James Lordan Dr Guy MacGowan	The Role of Specialist Palliative Care Services in the Management of Patients with Pulmonary Arterial Hypertension; A Review of Current Practice	2014
Dr Lee Borthwick Professor Andrew Fisher	TNF- α/IL-17 synergy inhibits IL-13 bioactivity via IL-13Rα2 induction	2014
Dr Lee Borthwick Professor Andrew Fisher	Cytokine mediated tissue fibrosis	2013
Jodie Birch Professor Andrew Fisher Professor Anthony De Soyza	DEEPER PHENOTYPING OF NON CF BRONCHIECTASIS THROUGH SPUTUM DIFFERENTIAL COUNTS	2013
Dr James Lordan Professor Andrew Fisher	Functional and Quality of Life Improvements in Treated Patients with Chronic Thromboembolic Pulmonary Hypertension	2013
Stephen Clark Professor Andrew Fisher Dr James Lordan Dr Gerard Meachery Dr Gareth Parry et al.	Improving Outcomes in Lung Transplantation for Cystic Fibrosis - A Unified Approach	2013
Dr Laura Mackay Dr James Lordan Professor Andrew Fisher	Isolation and characterisation of human pulmonary microvascular endothelial cells from patients with severe emphysema	2013
Dr James Lordan Dr Gerard Meachery Professor Andrew Fisher Dr Gareth Parry	Pregnancy after Lung Transplantation: A Single Center Experience	2013
Professor Andrew Fisher	Review of the British Thoracic Society Winter Meeting 2012, 5 to 7 December, London, UK	2013
Jen Birch Dr Gavin Johnson Professor Christopher Ward Dr John Taylor Dr Joao Passos et al.	Small Airway Epithelial Cell Senescence Present in COPD and Bronchiectasis?	2013
Dr Lee Borthwick Dr Rahul Mahida Andrew Walker Aaron Gardner Wona Suwara et al.	TNFα From Classically Activated Macrophages Accentuates Epithelial to Mesenchymal Transition in Obliterative Bronchiolitis	2013
Therese Small Professor Andrew Fisher Dr James Lordan	Treatment Outcomes in Pulmonary Arterial Hypertension (PHA) Associated with Systemic Sclerosis (Sscl.) in Matched Groups Using Either Bosentan or Sildenafil Monotherapy	2013
Therese Small Vicky Ryan Dr James Lordan Professor Andrew Fisher Dr Gerard Meachery et al.	A Randomised Controlled Trial of Azithromycin Therapy in Bronchiolitis Obliterans Syndrome (BOS) Post Lung Transplantation	2012
Professor Andrew Fisher Dr James Lordan	Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland	2012
Dr Rahul Mahida Dr Sarah Wiscombe Professor Andrew Fisher	Current status of lung transplantation	2012
Marta Gorowiec Dr Lee Borthwick Dr Sean Parker Emeritus Professor John Kirby Dr Gabriele Saretzki et al.	Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a TGF-beta 1-dependent mechanism	2012
Wona Suwara Dr Lee Borthwick Dr Rahul Mahida Dr Nicola Green Aaron Gardner et al.	Interleukin-1 Alpha (IL-1α) Released from Injured Lung Epithelium is a Critical Alarmin Driving Activation of a Potent Inflammatory Phenotype in Lung Fibroblasts	2012
Dr Nicola Green Wona Suwara Dr Lee Borthwick Professor Derek Mann Professor Andrew Fisher et al.	Interleukin-33 in Chronic Lung Disease	2012
Dr Joaquim Majo Dr Rahul Mahida Dr Neelima Thampy Dr Fiona Black Dr Gerard Meachery et al.	Prospective Evaluation of Alveolar and Bronchiolar C4d Expression in Transbronchial Biopsies from Lung Transplanted Recipients	2012
Professor Andrew Fisher	Pulmonary hypertension and lung transplantation: Thorax publication activity review 2008-2010	2012
Professor Andrew Fisher	Review of the British Thoracic Society Winter Meeting 2011, 7-9 December, London, UK	2012
Professor John Dark Danai Karamanou Stephen Clark Dr Brian Watson Professor Andrew Fisher et al.	Successful Transplantation of Unusable Donor Lungs Using Ex-Vivo Lung Perfusion: The Newcastle Experience	2012
Dr John Perry Dr Gerard Meachery Dr James Lordan Professor Andrew Fisher Professor Kate Gould et al.	Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas aeruginosa Using Multiple Combination Bactericidal Testing	2012
Dr Aaron Ions Gardner Professor Andrew Fisher Christine Richter Grace Johnson Dr Elizabeth Moisey et al.	The Critical Role of TAK1 in Accentuated Epithelial to Mesenchymal Transition in Obliterative Bronchiolitis after Lung Transplantation	2012
Dr Lee Borthwick Aaron Gardner Professor Anthony De Soyza Professor Derek Mann Professor Andrew Fisher et al.	Transforming Growth Factor-β1 (TGF-β1) Driven Epithelial to Mesenchymal Transition (EMT) is Accentuated by Tumour Necrosis Factor α (TNFα) via Crosstalk Between the SMAD and NF-κB Pathways	2012
Dr Lee Borthwick Dr Aaron Ions Gardner Professor Anthony De Soyza Professor Derek Mann Professor Andrew Fisher et al.	Transforming Growth Factor-β1 (TGF-β1) Driven Epithelial to Mesenchymal Transition (EMT) is Accentuated by Tumour Necrosis Factor α (TNFα) via Crosstalk Between the SMAD and NF-κB Pathways	2012
Dr Lee Borthwick Dr John Perry Dr Malcolm Brodlie Professor Christopher Ward Katherine Gould et al.	Pseudomonas aeruginosa accentuates epithelial-to-mesenchymal transition in the airway	2011
Dr Cath Huntley Professor Andrew Fisher	A review of the British Thoracic Society scientific meeting 1-3 December 2010	2011
Dr Rahul Mahida Monika Suwara Dr Gavin Johnson Professor Derek Mann Dr Lee Borthwick et al.	Alarmins in bronchiolitis obliterans syndrome after lung transplantation	2011
Professor Andrew Fisher	Azithromycin and bronchiolitis obliterans syndrome after lung transplantation: is prevention better than cure?	2011
Professor Andrew Fisher Professor Kate Gould Dr Gerard Meachery Dr James Lordan	Cystic fibrosis, lung transplantation and clostridium difficile associated disease	2011
Dr Lee Borthwick Phil Botha Dr Malcolm Brodlie Aaron Gardner Dr David Bourn et al.	Is CFTR-delF508 Really Absent from the Apical Membrane of the Airway Epithelium?	2011
Professor Andrew Fisher	Lung Transplantation and Lung Cancer: Is There a Link?	2011
Dr Malcolm Brodlie Dr Michael McKean Dr Amy Anderson Professor Catharien Hilkens Professor Andrew Fisher et al.	Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease	2011
Dr Nigel Kirkham Dr James Lordan Professor Andrew Fisher	Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension	2011
Dr Gerard Meachery Anne Nicholson Dr James Lordan Professor Andrew Fisher Professor Kate Gould et al.	Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas Aeruginosa	2011
Dr James Lordan Professor Andrew Fisher Dr Guy MacGowan	Ten Year Survival in Incident Cases of Idiopathic Pulmonary Arterial Hypertension (IPAH) in the Modern Era	2011
Dr Hannah Walden Dr Abigail Vallance Danai Karamanou Christopher Fox Dr Anthony Rostron et al.	The Alarmin HMGB1 Is an Inflammatory Mediator in Brain Death Induced Lung Damage	2011
Dr Katy Hester Dr Sarah Wiscombe Dr Gareth Parry Dr Gerard Meachery Professor Anthony De Soyza et al.	The impact of BMI on survival of patients with cystic fibrosis undergoing lung transplantation: a single centre experience	2011
Professor Andrew Fisher	The mortality of treated acute PE [reply]	2011
Dr Sergey Savelev Dr John Perry Dr Stephen Bourke Professor Robert Taylor Professor Andrew Fisher et al.	Volatile biomarkers of Pseudomonas aeruginosa in cystic fibrosis and non cystic fibrosis bronchiectasis	2011
Professor Andrew Fisher	Authors' reply	2010
Dr Malcolm Brodlie Dr Michael McKean Dr Joseph Gray Professor Andrew Fisher Dr James Lordan et al.	Ceramide is Increased in the Lower Airway Epithelium of People with Advanced Cystic Fibrosis Lung Disease	2010
Dr Elizabeth Moisey Dr Lee Borthwick Dr John Perry Professor Anthony De Soyza Professor Andrew Fisher et al.	Cigarette smoke dysregulates pro-inflammatory cytokine release from airway epithelial cells and macrophages in response to haemophilus influenzae	2010
Dr Anthony Rostron Dr David Cork Vassillios Avlonitis Professor Andrew Fisher Professor John Dark et al.	Contribution of Toll-Like Receptor Activation to Lung Damage After Donor Brain Death	2010
Dr Hannah Walden Danai Karamanou Christopher Fox Dr Anthony Rostron Emeritus Professor John Kirby et al.	Evaluation of secretory leucoprotease inhibitor (SLPI) as an anti-inflammatroy therapy for donor lung inflammation	2010
Dr Sergey Savelev Dr John Perry Dr Stephen Bourke Professor Roy Taylor Professor Andrew Fisher et al.	Identification of pseudomonas aeruginosa infection via volatile organic compounds in sputum headspace gases	2010
Monika Suwara Dr Lee Borthwick Professor Jelena Mann Professor Andrew Fisher Professor Derek Mann et al.	IL-1 IS A KEY EPITHELIAL ALARMIN WHICH PROMOTES FIBROBLAST ACTIVATION	2010
Dr Lee Borthwick Marta Gorowiec Dr Malcolm Brodlie Professor Christopher Ward Dr James Lordan et al.	Inflammation and Epithelial to Mesenchymal Transition in Lung Transplant Recipients: Role in Dysregulated Epithelial Wound Repair	2010
Dr Abigail Vallance Dr Hannah Walden Danai Karamanou Christopher Fox Dr Anthony Rostron et al.	Investigating HMGB1 as a potential inflammatory mediator in brain death induced lung damage	2010
Dr Andrew Robertson Professor Christopher Ward Therese Small Dr James Lordan Professor Andrew Fisher et al.	Longitudinal changes in gastro-oesophageal reflux from three months to six months post lung transplantation	2010
Aaron Gardner Dr Lee Borthwick Professor Andrew Fisher	Lung epithelial wound healing in health and disease	2010
Professor Anthony De Soyza Dr Gerard Meachery Dr Katy Hester Anne Nicholson T Pillay et al.	Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: A single-center experience	2010
Dr Laura Mackay Dr Hannah Walden Aaron Gardner Dr Lee Borthwick Professor Andrew Fisher et al.	Microvascular endothelial cell apoptosis and dysregulation of vascular endothelial growth factor receptor 2 (VEGF-R2) in response to cigarette smoke. New insights into the pathogenesis of emphysema	2010
Dr Malcolm Brodlie Dr Michael McKean Dr John Perry Dr Burns Verdon Dr Michael Gray et al.	Primary bronchial epithelial cell culture from explanted cystic fibrosis lungs	2010
Danai Karamanou Dr Hannah Walden Stephen Clark Professor John Dark Professor Andrew Fisher et al.	The Effect of Ex-Vivo Perfusion on the Inflammatory Profile of the Donor Lung	2010
Danai Karamanou Dr John Perry Dr Hannah Walden Katherine Gould Professor Andrew Fisher et al.	The Effect of Ex-Vivo Perfusion on the Microbiological Profile of the Donor Lung	2010
Dr Lee Borthwick Dr Malcolm Brodlie Professor Christopher Ward Dr John Perry Professor Anthony De Soyza et al.	The M1 macrophage phenotype accentuates TGF-beta 1 driven epithelial to mesenchymal transition (EMT) via the secretion of TNF alpha	2010
Dr Aaron Ions Gardner Dr Malcolm Brodlie Professor Derek Mann Dr Lee Borthwick Professor Andrew Fisher et al.	The role of transforming growth factor-beta activated kinase-1 (TAK-1) in the development of airway fibrosis	2010
Dr Andrew Robertson Professor Michael Griffin Professor Christopher Ward Professor Jeffrey Pearson Professor John Dark et al.	Aspiration in the Immediate Post Lung Transplantation Period	2009
Dr Andrew Robertson Professor Christopher Ward Professor Jeffrey Pearson Professor Andrew Fisher Dr James Lordan et al.	Aspiration Secondary to Gastro-Oesophageal Reflux but not Duodenal Reflux Occurs in the Immediate Post Lung Transplantation Period	2009
Dr Ian Forrest Professor Christopher Ward Vicky Ryan Dr Gavin Johnson Dr James Lordan et al.	Bronchalveolar Lavage Neutrophilia and MMP-9 at 3 Months Post Lung Transplantation May Predict the Development of BOS	2009
Professor Christopher Ward Julie Diboll Professor Andrew Fisher Dr Malcolm Brodlie Dr James Lordan et al.	Bronchial epithelial cells cultured from clinically stable lung allograft patients promote the development of macrophages from monocytes rather than dendritic cells	2009
Dr Malcolm Brodlie Dr Michael McKean Professor Andrew Fisher Dr James Lordan Professor Christopher Ward et al.	Ceramide is increased and associated with neutrophilic inflammation in the lower airway epithelium of people with cystic fibrosis	2009
Dr Lee Borthwick Dr Sean Parker Kate Brougham Marta Gorowiec Professor Christopher Ward et al.	Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation	2009
Professor Andrew Fisher	Identification of those at risk after acute pulmonary embolism	2009
Professor Christopher Ward Professor Jeffrey Pearson Therese Small Dr James Lordan Professor Andrew Fisher et al.	Longitudinal changes in gastro-oesophageal reflux from 3 months to 6 months after lung transplantation	2009
Dr Lee Borthwick Clare Pate Dr Joaquim Majo Professor Andrew Fisher	Morphometric comparison of airway remodelling in chronic obstructive pulmonary disease and obliterative bronchiolitis	2009
Dr Abraham Samuel Professor Andrew Fisher Professor John Dark	Novalung enables protective ventilation in acute lung injury	2009
Dr Lee Borthwick Dr Malcolm Brodlie Professor Christopher Ward Dr James Lordan Emeritus Professor John Kirby et al.	Pro-inflammatory Cytokines IL-1 beta and TNT alpha, but Not IL-8, Cause Aberrant Lung Epithelial Wound Repair Via TGF-beta 1 Driven Epithelial to Mesenchymal Transition (EMT)	2009
Dr Lee Borthwick Dr John Perry Professor Andrew Fisher Professor Anthony De Soyza	Proinflammatory potential of pseudomonas aeruginosa in macrophage models: Importance of clinical origin?	2009
Dr Malcolm Brodlie Dr Michael McKean Professor Andrew Fisher Dr James Lordan Professor Christopher Ward et al.	Reticular basement membrane thickening in end-stage cystic fibrosis lung disease	2009
Rachel Stovold Dr Ian Forrest Dr James Lordan Professor Andrew Fisher Professor John Dark et al.	Temporal Patterns of Lung Pepsin Levels in Allografts Suggest Aspiration Is an Ongoing Injury, Which Can Occur Early Following Lung Transplantation	2009
Danai Karamanou Dr Hannah Walden Stephen Clark Professor John Dark Professor Andrew Fisher et al.	The effect of ex vivo lung perfusion on proinflammatory and anti-inflammatory cytokines in the human lung	2009
Dr Sean Parker Dr Lee Borthwick Professor Christopher Ward Dr James Lordan Dr Gabriele Saretzki et al.	Airway epithelial cell senescence in the lung allograft	2008
Dr Laura Mackay Professor Andrew Fisher	An algorithm for referral of patients with IPF for lung transplantation - Author's reply	2008
Dr Rachel Anderson Professor Christopher Ward Dr Ian Forrest Dr James Lordan Professor Andrew Fisher et al.	Antimicrobial Peptides in Lung Transplant Recipients with Bronchiolitis Obliterans Syndrome	2008
Dr Laura Mackay Professor Andrew Fisher	Authors' reply	2008
Phil Botha Professor Andrew Fisher	Author's reply: De novo or persistent pseudomonal airway colonization after lung transplantation: Importance for bronchiolitis obliterans syndrome?	2008
Adillah Binti Yusof Dr Ian Forrest Therese Small Debra Jones Professor Andrew Fisher et al.	Azithromycin attenuates effects of lipopolysaccharide on lung allograft bronchial epithelial cells	2008
Dr Ian Forrest Dr Gavin Johnson Therese Small Professor Andrew Fisher Emeritus Professor Tim Cawston et al.	Azithromycin attenuates lipopolysaccharide-mediated release of interleukin-8 and GM-CSF from primary bronchial epithelial cells derived from stable lung transplant recipients	2008
Sergey Savelev Professor Anthony De Soyza Anne Nicholson Dr John Perry Emerita Professor Marion Petrie et al.	Developing a non-invasive test for pseudomonas detection: towards an electronic nose	2008
Rachel Stovold Professor Andrew Fisher Dr James Lordan Professor Jeffrey Pearson Professor Christopher Ward et al.	Does pepsin in gastric juice aspirated into the lung allograft stimulate mucus hypersecretion?	2008
Rachel Stovold Dr Ian Forrest Dr James Lordan Professor Andrew Fisher Professor Jeffrey Pearson et al.	Longitudinal assessment of pepsin levels in lung allografts suggests aspiration is an ongoing injury, which can occur early following lung transplantation	2008
Chris Wigfield Therese Small Professor John Dark Professor Andrew Fisher	Lung function after single lung transplantation (SLTx): Emphysema versus pulmonary fibrosis	2008
Professor Anthony De Soyza Dr James Lordan Professor Andrew Fisher Professor John Dark Professor Kate Gould et al.	Outcomes of lung transplantation for cystic fibrosis in a large UK cohort	2008
Marta Gorowiec Dr Lee Borthwick Marcin Pekalski Dr James Lordan Professor Christopher Ward et al.	Oxidative stress induces epithelial to mesenchymal transition in human lung epithelial cells through transforming groeth factor beta and integrin beta6-dependent mechanism	2008
Dr Lee Borthwick Kate Brougham Professor Christopher Ward Dr James Lordan Emeritus Professor John Kirby et al.	Pro-inflammatory cytokines dysregulate lung epithelial wound repair via epithelial to mesenchymal transition	2008
Phil Botha Dr Rachel Anderson Dr James Lordan Professor John Dark Katherine Gould et al.	Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome	2008
Dr Andrew Robertson Professor Michael Griffin Professor Christopher Ward Professor Jeffrey Pearson Anne Bredenoord et al.	Qualitative and quantitative assessments of aspiration in the immediate post-lung transplantation period	2008
Emeritus Professor Mike Sir Michael Rawlins Dr Ian Forrest Therese Small Debra Jones Professor Andrew Fisher et al.	Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients	2008
Dr Ian Forrest Therese Small Professor Andrew Fisher Emeritus Professor Tim Cawston Professor Christopher Ward et al.	Simvastatin potentially decreases neutrophilic inflammation and remodelling in the transplanted airway	2008
Dr Malcolm Brodlie Dr Michael McKean Dr John Perry Anne Nicholson Professor Jeffrey Pearson et al.	The culture of primary bronchial epithelial cells from the lungs of people with cystic fibrosis removed at the time of transplantation: a model to study cystic fibrosis lung disease	2008
Dr Joaquim Majo Dr Sean Parker Dr Fiona Black Dr James Lordan Professor Andrew Fisher et al.	The role of trausbronchial biopsies in the diagnosis of obliterative bronchiolitis: Time for a re-evaluation?	2008
Dr Lee Borthwick Sally Maloney Dr Rachel Anderson Professor Christopher Ward Dr James Lordan et al.	Transforming growth factor beta 1 suppresses secretory leucoprotease inhibitor release in response to infection in lung epithelial cells	2008
Dr Lee Borthwick Dr Sean Parker Marta Gorowiec Professor Christopher Ward Dr James Lordan et al.	Tumour necrosis factor-α accentuates transforming growth factor-β driven epithelial to mesenchymal transition (EMT) in airway epithelial cells from lung transplant recipients	2008
Dr Laura Mackay Professor Christopher Ward Dr James Lordan Professor Andrew Fisher	Alveolar septae in severe end-stage emphysema show morphological evidence of dysregulated mesenchymal cell proliferation and loss of microvascularity	2007
Dr John Perry Professor Andrew Fisher Professor Kate Gould	Antagonism between colistin and meropenem in Pseudomonas aeruginosa isolates from lung transplant patients	2007
Dr Laura Mackay Dr Guy MacGowan Professor Andrew Fisher Dr James Lordan	Correlation of NT-probrain natriuretic peptide (NTproBNP) and haemodynamics, in patients with pulmonary arterial hypertension (PAH)	2007
Dr Ian Forrest Professor Christopher Ward Debra Jones Professor Andrew Fisher Emeritus Professor Tim Cawston et al.	Effect of azithromycin on primary bronchial epithelial cells derived from stable lung allografts	2007
Phil Botha Professor Andrew Fisher Professor John Dark Stephen Clark	Inhaled nitric oxide for modulation of ischemia-reperfusion injury in lung transplantation	2007
Marta Gorowiec Dr Sean Parker Dr Lee Borthwick Professor Christopher Ward Dr James Lordan et al.	Oxidative stress increases transforming growth factor-beta expression and drives epithelial to mesenchymal transition in human lung epithelial cells	2007
Professor Andrew Fisher Professor Kate Gould Dr James Lordan Professor John Dark	Pseudomembranous colitis in four patients with cystic fibrosis following lung transplantation	2007
Dr Laura Mackay Dr Rachel Anderson Dr James Lordan Professor Andrew Fisher	Pulmonary fibrosis: Rate of disease progression as a trigger for referral for lung transplantation	2007
Professor Andrew Fisher	Selecting Patients Suitable for Lung Transplantation: the art of balancing risks	2007
Dr Sean Parker Professor Christopher Ward Dr James Lordan Dr Gabriele Saretzki Professor Andrew Fisher et al.	Stress-induced premature senescence in airway epithelium and accelerated lung allograft aging	2007
Dr John Perry Professor Kate Gould Dr Muhammad Raza Professor Andrew Fisher	Synergistic activities of twelve agents tested as triple combinations against 30 strains of multiresistant Pseudomonas aeruginosa and Burkholderia cepacia isolated pre and post lung transplantation	2007
Dr Rachel Anderson Dr Lee Borthwick Dr James Lordan Professor Andrew Fisher	The effect of calcineurin inhibitors (CNI) on the release of secretory leucoproteinase inhibitor (SLPI) by lung epithelial cells in the presence of transforming growth factor-beta (TGF-beta)	2007
Professor Kate Gould Professor Andrew Fisher Dr James Lordan Professor John Dark	Twenty six years experience of lymphoproliferative disease following lung transplantation (PTLD)	2007
Dr Rachel Anderson Dr Ian Forrest Dr James Lordan Professor Andrew Fisher	Antimicrobial peptides and airway innate immunity in the pathophysiology of bronchiolitis obliterans syndrome (BOS) after lung transplantation	2006
Professor Andrew Fisher Phil Botha Professor Kate Gould	Assessment of Pseudomonas aeruginosa colonisation post lung transplantation	2006
Professor Andrew Fisher	Clinical trials of immunosuppression in lung transplantation: A coming of age	2006
Phil Botha Dr Rachel Anderson Dr James Lordan Professor John Dark Professor Kate Gould et al.	Colonization of lung transplant recipients with Pseudomonas Aeruginosa and the development of bronchiolitis obliterans syndrome.	2006
Dr Lee Borthwick Professor Christopher Ward Dr James Lordan Professor Andrew Fisher	Epithelial mesencymal transition occurs in primary airway epithelial cells in response to transforming growth factor-beta and epidermal growth factor	2006
Rachel Stovold Dr Ian Forrest Dr Desmond Murphy Professor Andrew Fisher Professor John Dark et al.	Evidence of increased gastric aspiration in acute lung allograft rejection	2006
Dr James Lordan Professor Andrew Fisher	Factors affecting suitability of patients for lung transplantation assessment in a cohort referred to a single centre 2000-05	2006
Dr Laura Mackay Therese Small Dr James Lordan Professor Andrew Fisher	Long term administration of intravenous (IV) Iloprost for pulmonary arterial hypertension	2006
Phil Botha Professor Andrew Fisher Professor John Dark	Marginal lung donors: A diminishing margin of safety?	2006
Dr Lee Borthwick Dr Sean Parker Professor Christopher Ward Dr James Lordan Professor Andrew Fisher et al.	Oxidative stress induces epithelial to mesenchymal transition in bronchial epithelial cells: A possible role in airway remodelling	2006
Dr Sean Parker Professor Christopher Ward Dr Fiona Black Dr James Lordan Dr Gabriele Saretzki et al.	Premature senescence of airway epithelial cells: A possible role in airway remodelling after human lung transplantation	2006
Dr Rachel Anderson Dr James Lordan Professor Andrew Fisher	The antimicrobial peptide, human beta defensin-2, in acute rejection after human lung transplantation	2006
Dr Rachel Anderson Dr Lee Borthwick Dr James Lordan Professor Andrew Fisher	The effect of immunosuppressants on secretory leucoproteinase inhibitor production by lung epithelium in the presence of transforming growth factor-beta	2006
Professor Christopher Ward Dr Ian Forrest Professor David Jones Dr Gary Pritchard Rachel Stovold et al.	The phosphodiesterase type IV (PDE IV) inhibitor cilomilast decreases pro-inflammatory cytokine production from primary bronchial epithelial cells derived from lung transplant recipients	2006
Dr Desmond Murphy Professor Christopher Ward David Jones Rachel Stovold Professor Andrew Fisher et al.	The phosphodiesterase type IV inhibitor cilomilast decreases pro-inflammatory cytokine production from primary bronchial epithelial cells in lung transplantation patients	2006
Phil Botha Dr Rachel Anderson Dr James Lordan Professor John Dark Professor Kate Gould et al.	The role of primary graft dysfunction or recurrent acute rejection episodes in the development of Pseudomonas colonisation after lung transplantation	2006
Dr Lee Borthwick Professor Christopher Ward Dr James Lordan Professor Andrew Fisher	Tumour necrosis factor-alpha accentuates transforming growth factor-beta driven epithelial to mesenchymal transition in lung epithelial cells	2006
Professor Christopher Ward Professor Anthony De Soyza Professor Andrew Fisher	A descriptive study of small airway reticular basement membrane thickening in clinically stable lung transplant recipients	2005
Professor Christopher Ward Dr Robert Rutherford Professor Andrew Fisher Dr James Lordan Professor John Dark et al.	Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome	2005
Professor Christopher Ward Dr Ian Forrest Professor Andrew Fisher Dr James Lordan	Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome (BOS) following lung transplantation	2005
Dr Laura Mackay Dr Rachel Anderson Dr James Lordan Professor John Dark Professor Andrew Fisher et al.	Factors influencing success of achieving lung transplantation in patients with pulmonary fibrosis placed on the waiting list 1999-2004	2005
Dr Robert Rutherford Professor Andrew Fisher Colin Hilton Professor Kate Gould Professor John Dark et al.	Functional status and quality of life in patients surviving 10 years after lung transplantation	2005
Professor Christopher Ward Dr Ian Forrest Dr Helen Robertson Emeritus Professor Tim Cawston Professor Andrew Fisher et al.	Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients	2005
Professor Andrew Fisher	Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: Predictors and outcomes	2005
Dr John O'Sullivan Professor Andrew Fisher Dr James Lordan Dr Guy MacGowan	The effect of bosentan on exercise capacity in patients with Eisenmenger's syndrome	2005
Professor Andrew Fisher Dr Robert Rutherford Dr James Lordan	The feasibility of complete withdrawal of oral corticosteroids following lung transplantation	2005
Dr Ian Forrest Professor Christopher Ward Professor Andrew Fisher Emeritus Professor Tim Cawston Dr James Lordan et al.	The potential role of interleukin-17 in airway inflammation and remodelling in post-transplant obliterative bronchiolitis	2005
Professor Bob Anderson Dr Ian Forrest Professor Christopher Ward Dr Gavin Johnson Dr James Lordan et al.	The pulmonary innate immune response to pseudomonas aeruginosa infection in human lung transplant recipients	2005
Professor Andrew Fisher	The role of pulmonary innate immunity after lung transplantation	2005
Professor Andrew Fisher Dr Robert Rutherford Dr Joseph Bozzino Professor John Dark	The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation	2005
Professor Andrew Fisher Professor John Dark	Objective assessment of criteria for selection of donor lungs suitable for transplantation	2004
Professor Andrew Fisher Professor John Dark	Objective evaluation of selection criteria to assess donor lung suitability show poor discrimination of infection or inflammation	2004
Professor Christopher Ward Professor Anthony De Soyza Professor Andrew Fisher	Reticular basement membrane thickening in airways of lung transplant recipients is not affected by inhaled corticosteroids	2004
Dr Robert Rutherford Professor Andrew Fisher Professor John Dark Colin Hilton	Functional status of 10 year survivors after lung transplantation	2003
Professor Christopher Ward Dr Ian Forrest Professor Anthony De Soyza Professor Andrew Fisher	Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients	2003
Vassillios Avlonitis Professor Andrew Fisher Emeritus Professor John Kirby Professor John Dark	Pulmonary transplantation: The role of brain death in donor lung injury	2003
Professor Christopher Ward Dr Ian Forrest Professor Anthony De Soyza Professor Andrew Fisher	The presence of quorum-sensing signal molecules in clinically stable lung	2003
Professor Andrew Fisher Dr Josephine Wardle Professor John Dark	Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS)	2002
Professor Caroline Relton Professor Andrew Fisher Professor Sir John Burn	Polymorphisms of the DNA repair gene XRCC1 and the frequency of somatic mutations at the glycophorin A locus in newborns	2002
Professor Christopher Ward Professor Anthony De Soyza Professor Andrew Fisher	The presence of quorum sensing signal molecules in clinically stable lung allograft recipients suggests bacterial biofilm biology	2002
Professor Andrew Fisher Professor John Dark	Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation	2001
Professor Anthony De Soyza Professor Andrew Fisher Therese Small	Inhaled corticosteroids and the treatment of lymphocytic bronchiolitis following lung transplantation	2001
Professor Andrew Fisher Professor John Dark	Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury	1999
Professor Andrew Fisher Professor Anthony De Soyza Therese Small	Sensitivity and specificity of exhaled nitric oxide in identifying graft inflammation in lung transplant recipients.	1999
Professor Anthony De Soyza Therese Small Professor Andrew Fisher	The effect of inhaled steroids on exhaled nitric oxide (eNO) in lung transplant recipients with lymphocytic bronchitis	1999